Featured Press Release

Personalized and Translational Medicine Summit 2010

The Personalized and Translational Medicine USA will be held at the Radisson Hotel Boston, 20-21 September 2010 - organized by EyeForPharma


Recent News

Genmab A/S (OMX: GEN) reports today that the last patient to be included in the planned interim analysis (N=132 patients) in the pivotal Phase III clinical trial of ofatumumab (HuMax-CD2) in refractory chronic lymphocytic leukemia (CLL) has now received the last scheduled treatment. (more)

infoQuant Ltd brings microarray technology closer to clinical use with its latest release of copy number analysis and interpretation software oneClickCGH and CGH Fusion for microarray-based comparative genomic hybridization tests (array CGH). (more)

Biotech Market Summary

symbol last price date time change open high low volume
AFFY 6.03 9/2/2010 4:00pm +0.05 5.93 6.09 5.91 546805
ILMN 44.76 9/2/2010 4:00pm +0.87 43.79 44.76 43.64 750197
ARNA 6.74 9/2/2010 4:00pm +0.17 6.69 6.78 6.53 6959992
VRUS 24.96 9/2/2010 4:00pm +0.30 25.22 25.22 24.37 84607
GENZ 70.80 9/2/2010 4:00pm +0.42 70.05 70.94 70.05 3492033
A 29.21 9/2/2010 4:00pm +0.92 28.47 29.25 28.35 2720263
MRK 35.35 9/2/2010 4:00pm -0.27 35.69 35.77 34.52 11571510
Current Issue Issue_vol1_num1_small

View Larger Cover

Log In or register
to view the
current issue or previous issues

Search
Advertisement Index_ad

How to move from Blockbuster to Nichebuster and deliver personalized medicine

100+ attendees for unrivalled networking.

Including Roche, Merck, GSK, Pfizer, Novartis, Abbott, Astranzeneca

20+ expert speakers for exclusive insight

Including Roche, QIAGEN, Roche Molecular Diagnostics, Abbott, Lundbeck, Merck, AstraZeneca, Siemens

Practical solutions and case studies for unmatched learning

The roadmap to personalized medicine and how to succeed with companion diagnostics

Learn more

Home | Current Issue | Previous Issues | News | Submit News | About